Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression.

Por Reed, J. A., McNutt, N. S., Prieto, V. G., Albino, A. P.
Publicado em 1994

A novel AKT3 mutation in melanoma tumours and cell lines

Por Davies, M A, Stemke-Hale, K, Tellez, C, Calderone, T L, Deng, W, Prieto, V G, Lazar, A J F, Gershenwald, J E, Mills, G B
Publicado em 2008

Phase II trial of imatinib mesylate in patients with metastatic melanoma

Por Kim, K B, Eton, O, Davis, D W, Frazier, M L, McConkey, D J, Diwan, A H, Papadopoulos, N E, Bedikian, A Y, Camacho, L H, Ross, M I, Cormier, J N, Gershenwald, J E, Lee, J E, Mansfield, P F, Billings, L A, Ng, C S, Charnsangavej, C, Bar-Eli, M, Johnson, M M, Murgo, A J, Prieto, V G
Publicado em 2008